In fact, the ability of DU145 human prostate cancer cells to develop tumors into nude mice is eliminated with Rad9A knockdown [72], and the in vitro proliferation of MCF-7 breast cancer cells is inhibited with Rad9A silencing [73]. Here, RAD9A is linked to prostate cancer.